Abstract: An electromagnetic valve and an air conditioning system are provided. The electromagnetic valve includes a valve bonnet and a valve seat. The valve bonnet includes a large-diameter section and a small-diameter section, the small-diameter section extends into a mounting groove and is affixed to a groove wall of the mounting groove, and the large-diameter section abuts against the valve seat. A first sealing surface is formed by the large-diameter section abuts against the valve seat, and a second sealing surface is formed by the small-diameter section is affixed to the groove wall of the mounting groove. The valve bonnet and the valve seat are connected in a hard sealing connection manner at the first sealing surface, and the valve bonnet and the valve seat are connected in a soft sealing connection manner at the second sealing surface.

Abstract: There are provided compounds, their preparation and their use in the treatment of KRAS-driven cancers. The compounds according to the invention (general formula Class III) disrupt dimerization of KRAS and are inhibitors of KRAS mutants such as KRAS G12D, KRAS G12V and KRAS 12C. Embodiments of the compounds according to the invention are selective inhibitors of KRAS mutants over the wild-type (WT) KRAS.

Abstract: An anhydrous heat transfer medium, comprising any one or a combination of at least two of cis-1-chloro-3,3,3-trifluoropropene, cis-1,1,1,4,4,4-hexafluorobutene or perfluorobutane methyl ether. The heat transfer medium does not require an external device to perform work on the heat transfer medium during a heat transfer process, and is anhydrous, non-combustible, non-conductive and environmentally friendly.

Abstract: There are provided compounds, their preparation and their use in the treatment of medical conditions including cancers and immune disorders.

Abstract: There are provided compounds, their preparation and their use in the treatment of KRAS-driven cancers. The compounds according to the invention (general formula Class III) disrupt dimerization of KRAS and are inhibitors of KRAS mutants such as KRAS G12D, KRAS G12V and KRAS 12C. Embodiments of the compounds according to the invention are selective inhibitors of KRAS mutants over the wild-type (WT) KRAS.

Abstract: An anhydrous heat transfer medium, comprising any one or a combination of at least two of cis-1-chloro-3,3,3 -trifluoropropene, cis-1,1,1,4,4,4-hexafluorobutene or perfluorobutane methyl ether. The heat transfer medium does not require an external device to perform work on the heat transfer medium during a heat transfer process, and is anhydrous, non-combustible, non-conductive and environmentally friendly.

Abstract: The present invention provides a process for preparing azoxystrobin, which is performed by reacting 2-cyanophenol or a salt thereof with a compound represented by formula I under the catalysis of a trimethylamine catalyst to obtain the azoxystrobin represented by formula II, which allows the yield of the product azoxystrobin to reach 98% or more, the yield of separated product to reach 95% or more and the post-processing to be simple. The trimethylamine catalyst can be recycled and reused in synthesizing the target product azoxystrobin, which not only reduces the cost but also reduces the total nitrogen and COD in wastewater. The advantages regarding of cost and environmental protection of the method according to the present invention are significant and thus the method is suitable for industrial production.

Abstract: The present invention provides a method for preparing azoxystrobin intermediates, comprising reacting compound A and dichloropyrimidine in the presence of a trimethylamine catalyst with the addition of a sodium methoxide solution in methanol or the addition of sodium methoxide and methanol separately to produce a mixture of compound B and compound C. Azoxystrobin intermediate compound B and compound C are synthesized from compound A in the present invention, which is catalyzed by using a trimethylamine catalyst, allowing the reaction to have high efficiency and high yield. In addition, the trimethylamine catalyst has a low boiling point and thus can be easily recycled so that the ammoniacal nitrogen content in wastewater can be reduced, and the difficulties and high costs for wastewater processing can be also reduced. The recycled trimethylamine catalyst can be reused in preparing intermediate compound B, which also has a high catalytic effect and can also achieve a high product yield.

Abstract: There are provided compounds, their preparation and their use in the treatment of medical conditions including cancers and immune disorders.

Abstract: Urea-based and bis-urea based compounds and analogues thereof are disclosed. These compounds are useful in the treatment of androgen-dependent diseases or disorders and androgen receptor-mediated diseases or disorders. Specifically, the compounds are useful in the treatment of diseases or disorders that are AR negative.